Functional differences between D1 and D5 revealed by high resolution imaging on live neurons

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Neuroscience (Impact Factor: 3.36). 09/2009; 164(2):463-9. DOI: 10.1016/j.neuroscience.2009.08.052
Source: PubMed


The interaction between the dopaminergic and glutamatergic systems governs normal behavior and is perturbed in many psychiatric disorders including schizophrenia. Hypofunction of the D1 family of receptors, to which the D(1) and D(5) subtypes belong, is a typical feature of schizophrenia. Here we have used confocal live cell imaging of neurons to examine the distinct roles of the D(1) and D(5) receptors in the intra-neuronal interaction with the glutamatergic system. Using fluorescently tagged D(1) or D(5) expressed in cultured striatal neurons, we show that both receptor subtypes are primarily transported via lateral diffusion in the dendritic tree. D(1) is to a much larger extent than D(5) expressed in spines. D(1) is primarily expressed in the head whereas D(5) is largely localized to the neck of the spine. Activation of N-methyl-D-aspartic acid (NMDA) receptors slowed the diffusion rate and increased the number of D(1) positive spines, while no effect on D(5) diffusion or spine localization could be observed. The observed differences between D(1) and D(5) can be attributed to structural differences in the C-terminus and its capacity to interact with NMDA receptors and PSD-95. Identification of a unique role of D(1) for the intra-neuronal interaction between the dopaminergic and glutamatergic systems will have implications for the development of more specific treatments in many neuropsychiatric disorders.

Download full-text


Available from: Sandeep Kumar, Jul 07, 2014
    • "Haloperidol, clozapine and olanzapine, are dopaminergic receptors antagonists and despite their lack of affinity to the NMDA-R, present a significant increase in glutamatergic transmission [17]. Some studies suggested that the blockage of the dopamine receptors D 2 and D 4 by haloperidol cause an increase in phosphorylation of the NR1 subunit by protein kinase, leading to sensitization of the glutamate receptor [18]. However, alternative studies, demonstrate no influence of haloperidol on NMDA-R activity in the prefrontal cortex of the rat [19]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Antagonists of the N-methyl-d-aspartate receptor (NMDA-R) are associated with symptoms of schizophrenia, leading to the hypothesis that NMDA-R hypofunction leads to the pathogenesis of disease. We evaluated the long-term effect of neuroleptic administration on the NMDA subunits via immunohistochemical analysis. Methods: Rats received olanzapine, clozapine and haloperidol before evaluation of the expression of the NR1, NR2A and NR2B subunit proteins in the hippocampal areas of the brain, via a densytometric analysis of immunoexpression in the rat hippocampus. Results: All of the neuroleptics examined caused a decrease in the expression of the NR1 subunit, and thus, one can assume that both olanzapine, clozapine and haloperidol decreased the number of NMDA receptors in the CA1 and CA2 areas of the brain. Conclusions: A decrease in hippocampal glutamatergic signalling after long-term neuroleptic administration may cautiously explain the incomplete effectiveness of these drugs in the therapy of schizophrenia-related cognitive disturbances.
    Pharmacological reports: PR 02/2015; 67(5). DOI:10.1016/j.pharep.2015.01.017 · 1.93 Impact Factor
  • Source
    • "This specific D (2)-receptor occupancy in the striatum in schizophrenia patients interacts with the antagonistic effects of 5-HT2A receptors [review by Pani et al. (123)]. D (1)-receptors and NMDA-receptors cooperate with each other (124). Furthermore, the intensification of D (2)-receptor antagonists by D (1)-receptor agonists results in better NMDA transmission, exemplified by the action of clozapine as a partial D (1)-receptor agonist (109). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dopamine is an inhibitory neurotransmitter involved in the pathology of schizophrenia.The revised dopamine hypothesis states that dopamine abnormalities in the mesolimbic and prefrontal brain regions exist in schizophrenia. However, recent research has indicated that glutamate, GABA, acetylcholine, and serotonin alterations are also involved in the pathology of schizophrenia. This review provides an in-depth analysis of dopamine in animal models of schizophrenia and also focuses on dopamine and cognition. Furthermore, this review provides not only an overview of dopamine receptors and the antipsychotic effects of treatments targeting them but also an outline of dopamine and its interaction with other neurochemical models of schizophrenia. The roles of dopamine in the evolution of the human brain and human mental abilities, which are affected in schizophrenia patients, are also discussed.
    Frontiers in Psychiatry 05/2014; 5. DOI:10.3389/fpsyt.2014.00047
  • Source
    • "In this study we quantified cytoplasmic D5Rs and D5Rs overlaying the plasma membrane on pyramidal cell somas, large dendrites and spines in the CA1 hippocampus. However, the position of a receptor is not fixed, as receptors constantly move laterally in the plasma membrane (Borgdorff and Choquet, 2002; Tardin et al., 2003; Kruusmagi et al., 2009) or circulate between the cytoplasm and the plasma membrane (Vickery and von Zastrow, 1999; He et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: A state of low dopaminergic activity has been implicated in attention-deficit/hyperactivity disorder (ADHD). The clinical symptoms of ADHD include inattention, impulsivity and hyperactivity, as well as impaired learning; dopaminergic modulation of the functions in the hippocampus is important to both learning and memory. To determine dopamine receptor density in a well-established animal model for ADHD, we quantified the dopamine D5 receptors in the hippocampus in the spontaneously hypertensive rat. We used immunofluorescence microscopy and immunogold electron microscopy to quantify the dopamine D5 receptor density on CA1 pyramidal cell somas and dendrites and dendritic spines in stratum radiatum and stratum oriens. The density of the dopamine D5 receptors was significantly lower in the cytoplasm of pyramidal cell somas in the spontaneously hypertensive rat compared to the control, indicating a reduced reservoir for insertion of receptors into the plasma membrane. Dopamine receptors are important for long term potentiation and long term depression, hence the deficit may contribute to the learning difficulties in individuals with the diagnosis of ADHD.
    Neuroscience 03/2013; 242. DOI:10.1016/j.neuroscience.2013.03.036 · 3.36 Impact Factor
Show more